Therapeutic interchange of fluoroquinolones at a medical center

American Journal of Health-System Pharmacy

Volumn 58, Issue 10, 2001, Pages 904-907

  Lomaestro, Ben M ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CENTER; HYPOTHESIS; PATIENT COMPLIANCE; POLICY; PRESCRIPTION; PRIORITY JOURNAL; PROBLEM SOLVING; PSEUDOMONAS AERUGINOSA; TEACHING HOSPITAL; WORK ENVIRONMENT;

EID: 0035873802     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.10.904     Document Type: Article

References (5)

1. Kim MK, Nightingale CH. Pharmacokinetics and pharmacodynamics of fluoroquinolones. In: Andriole VT, ed. The quinolones. Chap. 5. 3rd ed. London: Academic Press; 2000.
2. Gatifloxacin package insert. Princeton, NJ: Bristol-Myers Squibb; 2000 Feb.
3. Levofloxacin package insert. Raritan, NJ: Ortho-McNeil Pharmaceutical; 2000 Feb.
4. Ball P. Quinolone-induced QT interval prolongation: a not so unexpected class effect. J Antimicrob Chemother. 2000; 45:557-9.
5. Andriole VT. Cardiotoxicity of antibiotics: what to make of a prolonged QTc interval. Paper presented at 40th lnterscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada; 2000 Sep 17-20.